Preclinical Remodeling of Human Prostate Cancer through the PTEN/AKT Pathway
Marco A. De Velasco(Kindai University), Hirotsugu Uemura(Kindai University)
Cited by 17
Related Papers
Evaluation of in vivo responses of sorafenib therapy in a preclinical mouse model of PTEN-deficient of prostate cancer
|Journal of Translational Medicine|2015|17